Cargando…
CD55 is over-expressed in the tumour environment
CD55 is a protein that protects cells from complement-mediated attack. 791Tgp72 is an antigen which has been used succesfully as a target for both tumour imaging and cancer vaccines. 791Tgp72 has recently been identified as CD55. Quantitative expression of CD55 in the tumour environment was therefor...
Autores principales: | Li, L, Spendlove, I, Morgan, J, Durrant, L G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363604/ https://www.ncbi.nlm.nih.gov/pubmed/11139317 http://dx.doi.org/10.1054/bjoc.2000.1570 |
Ejemplares similares
-
Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer
por: Fosså, A, et al.
Publicado: (2000) -
The distinct role of CD4(+) and CD8(+) T-cells during the anti-tumour effects of targeted superantigens
por: Litton, M J, et al.
Publicado: (1999) -
The expression profile for the tumour suppressor gene PTEN and associated polymorphic markers
por: Hamilton, J A, et al.
Publicado: (2000) -
The active form of Helicobacter pylori vacuolating cytotoxin induces decay‐accelerating factor CD55 in association with intestinal metaplasia in the human gastric mucosa
por: Kaneko, Kazuyo, et al.
Publicado: (2022) -
Trafficking of ‘immune’ CD4(+)/CD8(+) T-lymphocytes into the RENCA tumour microcirculation in vivo in mice
por: Ali, S A, et al.
Publicado: (2000)